Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA confirms recall for Impella controllers | New funding for AI | Persistent MR & TAVR | Care at for-profit hospitals
Monday, September 28, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA confirms Class I recall for Impella heart pump controllers

Clinicians can continue using these devices as they await a replacement. The FDA first issued an early alert about this issue in August. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA confirms Class I recall for Impella heart pump controllers

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
Clinicians can continue using these devices as they await a replacement. The FDA first issued an early alert about this issue in August. 
READ MORE >

Government-funded program wants better AI for managing heart failure in the US

The long-term goal is to bring 24-7 cardiac care to every American, even those living in counties with no cardiologists.

READ MORE >
The U.S. government's Advanced Research Projects Agency for Health (ARPA-H) recently launched a competition to build patient-facing artificial intelligence (AI), a supervisory agentic AI, and a scalable deployment plan. The agency's stated goal is to bring 24-7 cardiac care to every American, even those living in nearly half of U.S. counties without any cardiologists.
Share on Twitter Share on Facebook Share on Linkedin

Government-funded program wants better AI for managing heart failure in the US

Share on Twitter Share on Facebook Share on Linkedin
The U.S. government's Advanced Research Projects Agency for Health (ARPA-H) recently launched a competition to build patient-facing artificial intelligence (AI), a supervisory agentic AI, and a scalable deployment plan. The agency's stated goal is to bring 24-7 cardiac care to every American, even those living in nearly half of U.S. counties without any cardiologists.
The long-term goal is to bring 24-7 cardiac care to every American, even those living in counties with no cardiologists.
READ MORE >

Persistent mitral regurgitation after TAVR more common among women than men

The study's authors emphasized that these data should be kept in mind when making treatment decisions for female patients with severe AS. 

READ MORE >
older patient with a doctor at their house
Share on Twitter Share on Facebook Share on Linkedin

Persistent mitral regurgitation after TAVR more common among women than men

Share on Twitter Share on Facebook Share on Linkedin
older patient with a doctor at their house
The study's authors emphasized that these data should be kept in mind when making treatment decisions for female patients with severe AS. 
READ MORE >

Heart attack patients treated at for-profit hospitals more likely to be readmitted

Readmission rates are getting lower over time among patients treated at nonprofit hospitals. At for-profit facilities, meanwhile, readmission rates have stayed relatively unchanged.

READ MORE >
Survival on the rise among high-risk pulmonary embolism patients.
Share on Twitter Share on Facebook Share on Linkedin

Heart attack patients treated at for-profit hospitals more likely to be readmitted

Share on Twitter Share on Facebook Share on Linkedin
Survival on the rise among high-risk pulmonary embolism patients.
Readmission rates are getting lower over time among patients treated at nonprofit hospitals. At for-profit facilities, meanwhile, readmission rates have stayed relatively unchanged.
READ MORE >

Featured Articles

Semaglutide is improving the heart health of millions—but how? Experts are stumped

“Our analyses could not fully ascribe the effects of semaglutide on cardiovascular disease to known risk factors with any certainty,” one researcher said after exploring years of data. "These results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug." 

READ MORE >
obesity semaglutide tirzepatide GLP-1 drugs weight loss
Share on Twitter Share on Facebook Share on Linkedin

Semaglutide is improving the heart health of millions—but how? Experts are stumped

Share on Twitter Share on Facebook Share on Linkedin
obesity semaglutide tirzepatide GLP-1 drugs weight loss
“Our analyses could not fully ascribe the effects of semaglutide on cardiovascular disease to known risk factors with any certainty,” one researcher said after exploring years of data. "These results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug." 
READ MORE >

Oral hormone replacement therapy increases blood clot risk

In addition, higher doses of oral HRT may slightly increase a woman's risk of experiencing a heart attack or stroke. 

READ MORE >
older female patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

Oral hormone replacement therapy increases blood clot risk

Share on Twitter Share on Facebook Share on Linkedin
older female patient and doctor
In addition, higher doses of oral HRT may slightly increase a woman's risk of experiencing a heart attack or stroke. 
READ MORE >

Will AI replace cardiologists?

AI-based tools are here to stay, but one expert does not see them replacing cardiologists anytime soon. Look at recent trends in radiology, he says, to get a better idea of what cardiology's future may look like.

READ MORE >
Sanjiv Narayan, MD, MBChB, MSc, FRCP, an American Heart Association volunteer, director of the electrophysiology research and atrial fibrillation program, and co-founder of the Stanford Arrhythmia Center at Stanford Medicine, sees AI at a major inflection point in cardiology, enabling cardiologists to become more efficient, gain more detailed insights into their patients' risk factors, better answers to clinical questions and help in navigating procedures. But, he said AI will not replace cardiologists.
Share on Twitter Share on Facebook Share on Linkedin

Will AI replace cardiologists?

Share on Twitter Share on Facebook Share on Linkedin
Sanjiv Narayan, MD, MBChB, MSc, FRCP, an American Heart Association volunteer, director of the electrophysiology research and atrial fibrillation program, and co-founder of the Stanford Arrhythmia Center at Stanford Medicine, sees AI at a major inflection point in cardiology, enabling cardiologists to become more efficient, gain more detailed insights into their patients' risk factors, better answers to clinical questions and help in navigating procedures. But, he said AI will not replace cardiologists.
AI-based tools are here to stay, but one expert does not see them replacing cardiologists anytime soon. Look at recent trends in radiology, he says, to get a better idea of what cardiology's future may look like.
READ MORE >

High-quality heart failure care is easy to find for many Americans—but care gaps remain

The Heart Failure Society of America has released a new comprehensive look at HF clinics in the United States. The report includes more than 300 programs that serve approximately 626,000 patients.

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

High-quality heart failure care is easy to find for many Americans—but care gaps remain

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
The Heart Failure Society of America has released a new comprehensive look at HF clinics in the United States. The report includes more than 300 programs that serve approximately 626,000 patients.
READ MORE >

In Case You Missed It

Artificial sweetener linked to much higher risk of heart attack, stroke or death

Xylitol, a sugar substitute found in chewing gum, baked goods and toothpaste, was associated with long-term cardiovascular risks in a new study of more than 17,000 adults.

READ MORE >
chewing gum
Share on Twitter Share on Facebook Share on Linkedin

Artificial sweetener linked to much higher risk of heart attack, stroke or death

Share on Twitter Share on Facebook Share on Linkedin
chewing gum
Xylitol, a sugar substitute found in chewing gum, baked goods and toothpaste, was associated with long-term cardiovascular risks in a new study of more than 17,000 adults.
READ MORE >

Stroke patients should start rehab as soon as possible

Stroke patients should begin their road to recovery as soon as they are medically stable, according to a new ASA/AHA guideline. In fact, starting within the first 48 hours is recommended to maximize the patient’s chance of a full recovery.

READ MORE >
stroke
Share on Twitter Share on Facebook Share on Linkedin

Stroke patients should start rehab as soon as possible

Share on Twitter Share on Facebook Share on Linkedin
stroke
Stroke patients should begin their road to recovery as soon as they are medically stable, according to a new ASA/AHA guideline. In fact, starting within the first 48 hours is recommended to maximize the patient’s chance of a full recovery.
READ MORE >

FDA clears new imaging software from AI company founded by cardiologists

The new software from Tennessee-based Heartvue.ai uses advanced AI algorithms to view, process and evaluate cardiac MRI scans. It was built to work with any existing cardiology or radiology workflow.

READ MORE >
artificial intelligence AI predictive analytics
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new imaging software from AI company founded by cardiologists

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI predictive analytics
The new software from Tennessee-based Heartvue.ai uses advanced AI algorithms to view, process and evaluate cardiac MRI scans. It was built to work with any existing cardiology or radiology workflow.
READ MORE >

In Other News

State AGs call for federal AI regs without further ado; Big Tech insider suspects cynical motives behind AI doomsday warnings

Some 26 attorneys general have signed onto an initiative urging Congress to federally regulate the AI industry “immediately.” One of the voices countering the call is coming from inside the Big Tech arena. 

READ MORE >
fleeing AI apocalypse
Share on Twitter Share on Facebook Share on Linkedin

State AGs call for federal AI regs without further ado; Big Tech insider suspects cynical motives behind AI doomsday warnings

Share on Twitter Share on Facebook Share on Linkedin
fleeing AI apocalypse
Some 26 attorneys general have signed onto an initiative urging Congress to federally regulate the AI industry “immediately.” One of the voices countering the call is coming from inside the Big Tech arena. 
READ MORE >

Motion-related repeat MRI sequences create considerable operational burden

Previous studies have estimated that upward of $115,00 in per-scanner revenue is lost each year, due to motion-driven MRI repeats. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Motion-related repeat MRI sequences create considerable operational burden

Share on Twitter Share on Facebook Share on Linkedin
Previous studies have estimated that upward of $115,00 in per-scanner revenue is lost each year, due to motion-driven MRI repeats. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup